Companies: 10,795·Total market cap: $144.5T
LENZ Therapeutics, Inc.

LENZ Therapeutics, Inc.

LENZNASDAQHealthcare● Active
$6.72
$-0.29(-4.14%)
Market Cap$210701528
P/E Ratio
52W High$50.4
52W Low$6.61
Overview

LENZ Therapeutics, Inc.(LENZ)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · LENZ · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$19.09M$0.00M$0.00M$15.00M$0.00M
Cost of Revenue$0.70M$0.06M$0.00M$0.00M$0.73M
Gross Profit$18.38M($0.06M)$0.00M$15.00M($0.73M)
Gross Margin %(computed)96.31%100.00%
Operating Expenses
R&D Expenses$18.67M$29.80M$59.50M$21.13M$37.93M
G&A Expenses$0.00M$0.00M$0.00M$0.00M$0.00M
Total Operating Expenses$109.52M$58.55M$72.43M$25.48M$59.71M
Operating Income($91.14M)($58.61M)($72.43M)($10.48M)($60.44M)
Operating Margin %(computed)-477.46%-69.89%
Interest Income$9.76M$8.55M$2.19M$0.00M$0.00M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($81.63M)($49.77M)($70.15M)($10.46M)($70.76M)
Income Tax Expense$0.50M$0.00M($0.18M)$0.35M$0.00M
Net Income($82.13M)($49.77M)($69.97M)($10.81M)($70.76M)
Net Margin %(computed)-430.25%-72.07%
Per Share & EBITDA
EPS (Basic)$-2.85$-2.34$-15.30$-12.89$-8.54
Wtd Avg Shares28.81M21.28M8.15M7.84M8.29M
EBITDA($90.85M)($49.71M)($72.41M)($10.47M)($70.03M)
EBITDA Margin %(computed)-475.96%-69.83%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · M

深入了解LENZ Therapeutics, Inc.

关于LENZ Therapeutics, Inc.(LENZ)损益表

LENZ Therapeutics, Inc.(LENZ)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,LENZ实现营收$0.02B,毛利润$0.02B(毛利率96.31%),净利润($0.08B)(净利率-430.25%)。

常见问题

LENZ · 4 问

LENZ Therapeutics, Inc.(LENZ)2025财年营收为$0.02B,同比up—%。

LENZ revenueLENZ salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08